0000874015-15-000040.txt : 20150309 0000874015-15-000040.hdr.sgml : 20150309 20150309194538 ACCESSION NUMBER: 0000874015-15-000040 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150305 FILED AS OF DATE: 20150309 DATE AS OF CHANGE: 20150309 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ISIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000874015 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330336973 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 BUSINESS PHONE: 7609319200 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Geary Richard S CENTRAL INDEX KEY: 0001442730 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19125 FILM NUMBER: 15686778 MAIL ADDRESS: STREET 1: C/O ISIS PHARMACEUTICALS, INC. STREET 2: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2015-03-05 0000874015 ISIS PHARMACEUTICALS INC ISIS 0001442730 Geary Richard S C/O ISIS PHARMACEUTICALS, INC. 2855 GAZELLE COURT CARLSBAD CA 92010 0 1 0 0 SVP, Development Common Stock 2015-03-05 2015-03-05 4 S 0 3015 71.668 D 4555 D Common Stock 2015-03-05 2015-03-05 4 M 0 80 11.27 A 4635 D Common Stock 2015-03-05 2015-03-05 4 S 0 80 71.668 D 4555 D Common Stock 2015-03-05 2015-03-05 4 M 0 8000 10.29 A 12555 D Common Stock 2015-03-05 2015-03-05 4 S 0 8000 71.668 D 4555 D Common Stock 2015-03-05 2015-03-05 4 M 0 7000 7.25 A 11555 D Common Stock 2015-03-05 2015-03-05 4 S 0 7000 70.318 D 4555 D Employee Stock Option (right to buy) 11.27 2015-03-05 2015-03-05 4 M 0 80 0 D 2014-01-04 2017-01-03 Common Stock 80 0 D Employee Stock Option (right to buy) 10.29 2015-03-05 2015-03-05 4 M 0 8000 0 D 2015-01-03 2018-01-02 Common Stock 8000 426 D Employee Stock Option (right to buy) 7.25 2015-03-05 2015-03-05 4 M 0 7000 0 D 2013-01-03 2019-01-02 Common Stock 7000 7035 D The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 2/3/2015 Acquired as a result of exercising a stock option pursuant to Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on 2/3/2015. Grant of 1/3/2012 to reporting person of stock options under the Isis Pharmacueticals, Inc. 1989 Stock Option Plan. 25% of the shares subject to the option vested and became exercisable on 1/3/2013. Thereafter, the remaining shares subject to the option vest and become exercisable in 36 equal monthly installments, at the rate of 6984 shares per year. Following this transaction, the option was exercisable as to 1,215 on 3/5/2015. /s/Richard S. Geary 2015-03-09